These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6996155)

  • 1. Response of malignant hypertension with refractory cardiac failure to captopril: A case report.
    Levin L; Logan K
    S Afr Med J; 1980 Aug; 58(5):217-8. PubMed ID: 6996155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats.
    Okamoto K; Ohta Y; Chikugo T; Shiokawa H; Morita N
    J Hypertens; 1991 Dec; 9(12):1105-17. PubMed ID: 1663966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
    Smith CD; Smith RD; Korn JH
    Arthritis Rheum; 1984 Jul; 27(7):826-8. PubMed ID: 6331462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive effect of an oral angiotensin I-converting enzyme inhibitor in two cases with malignant hypertension (author's transl)].
    Mizuno K; Gotho M; Tsutsui K; Yamazaki M; Shigetomi S; Kudo S; Matsui J; Haruyama K; Nakamura I; Toki T; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):1-12. PubMed ID: 7026848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of captopril in relieving congestive heart failure developing during management of hypertension. Case report.
    McNay JL; Dole WP
    Hypertension; 1983; 5(3):390-3. PubMed ID: 6341222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.
    Oberfield SE; Case DB; Levine LS; Rapaport R; Rauh W; New MI
    J Pediatr; 1979 Oct; 95(4):641-4. PubMed ID: 383935
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral converting enzyme inhibitor in malignant hypertension.
    Griswold W; McNeal R; O'Connor D; Reznik V; Mendoza S
    Arch Dis Child; 1982 Mar; 57(3):235-7. PubMed ID: 6280623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hypertension in a child with hemolytic-uremic syndrome treated with captopril.
    Monnens L; Drayer J; De Jong M
    Acta Paediatr Scand; 1981 Jul; 70(4):583-5. PubMed ID: 7032189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
    Lindsjö M; Danielson BG; Weiss L; Wikström B
    Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hypertensive crisis with captopril].
    Almeida FA; Ribeiro AB; Marson O; Kohlmann O; Alves Filho G; Saragoça MA; Ramos OL
    Arq Bras Cardiol; 1981 Nov; 37(5):425-9. PubMed ID: 7052030
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined treatment with minoxidil and captopril in refractory hypertension.
    Traub YM; Levey BA
    Arch Intern Med; 1983 Jun; 143(6):1142-4. PubMed ID: 6344825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.